Dantrolene Sodium Salt: Mechanistic Benchmarks in Calcium Signaling and RyR Antagonism

Executive Summary: Dantrolene sodium salt is a potent, calmodulin-dependent ryanodine receptor antagonist with an IC50 of 5.9 ± 0.3 nM for RyR2, validated in both in vitro and in vivo models (APExBIO). It exhibits high selectivity for RyR-mediated intracellular calcium release, a pathway implicated in ischemia, hypoxia, neurodegeneration, and synthetic lethality workflows (Dantrolene, sodium salt: A Benchmark Ryanodine Receptor A...). Mechanistic studies show that its RyR antagonism is strictly calmodulin-dependent, affecting calcium wave frequency and amplitude only in the presence of calmodulin. The compound is rigorously quality-controlled (HPLC, NMR, >98% purity) and supports advanced applications in CRISPR genome editing and disease modeling (Nature Communications, 2025).

Biological Rationale

Ryanodine receptors (RyRs) are calcium release channels located on the endoplasmic and sarcoplasmic reticulum membranes. They regulate calcium flux critical for muscle contraction, neuronal excitability, and cell death pathways (Nature Communications, 2025). Dysregulation of RyR-mediated calcium release is linked to pathological conditions, including ischemia, hypoxia, seizures, trauma, anesthesia complications, and neurodegenerative diseases (Advanced Insights into Ryanodine). Calcium homeostasis is also central to DNA double-strand break (DSB) repair and synthetic lethality strategies in gene editing.

Mechanism of Action of Dantrolene, sodium salt

Dantrolene sodium salt (SKU B6329, APExBIO) is a selective ryanodine receptor antagonist. It binds RyR2 with an IC50 of 5.9 ± 0.3 nM, inhibiting receptor activity and thus calcium release from intracellular stores (product page). Mechanistically, inhibition occurs only in the presence of calmodulin, as shown in mouse cardiomyocytes where both calcium wave frequency and amplitude are reduced only when calmodulin is present (Benchmark RyR Antagonist). This mechanism underpins its specificity and utility in dissecting calcium signaling cascades.

Evidence & Benchmarks

• Dantrolene sodium salt inhibits RyR2 with an IC50 of 5.9 ± 0.3 nM (in vitro, buffer pH 7.2, 22°C) (APExBIO).
• Calmodulin-dependency is demonstrated by lack of effect in calmodulin-deficient conditions (mouse cardiomyocyte model) (Review Article).
• In vivo, dantrolene reduces pancreatic trypsin activity and mitigates cellular injury in mouse caerulein-induced pancreatitis models (Nature Communications, 2025).
• High purity (>98%) is verified by HPLC and NMR for each lot; molecular weight is 336.23 g/mol (APExBIO).
• Enables reproducible inhibition of calcium signaling in CRISPR/Cas9-edited hiPSCs, supporting synthetic lethality screens (Targeting RyR Signaling).

Applications, Limits & Misconceptions

Dantrolene sodium salt is used as a research tool in:

• Calcium signaling modulation assays in cardiomyocytes, neurons, and pancreatic cells.
• Gene editing workflows requiring precise intracellular calcium control (e.g., CRISPR HDR/NHEJ pathway modulation).
• Models of neurodegenerative disease, ischemia, and hypoxia (Advanced Insights).
• Synthetic lethality screens to exploit vulnerabilities in DNA repair-deficient cells (Nature Communications, 2025).

This article extends the practical discussions in "Dantrolene, sodium salt (SKU B6329): Practical Solutions ..." by providing new mechanistic updates and recent benchmark data from in vivo and gene editing models.

Common Pitfalls or Misconceptions

• Solubility limitations: Dantrolene sodium salt is insoluble in water and ethanol; only soluble in DMSO (≥12.2 mg/mL).
• Short-term solution stability: Solutions are stable only for short periods; degradation may occur if stored long-term even at room temperature.
• Calmodulin-dependency: No inhibition occurs without calmodulin; not suitable for RyR assays lacking calmodulin.
• Not a pan-calcium channel blocker: Dantrolene is selective for RyRs, not voltage-gated or IP3-sensitive calcium channels.
• Not a therapeutic formulation: Research-use only; not suitable for clinical administration.

Workflow Integration & Parameters

• Preparation: Dissolve compound in DMSO to prepare stock solutions at ≥12.2 mg/mL; dilute further as needed for assays (APExBIO).
• Storage: Store powder at room temperature; use solutions immediately for optimal activity.
• Quality Control: Each lot is supplied with HPLC and NMR data, confirming >98% purity.
• Experimental design: Include calmodulin in RyR inhibition assays; confirm activity with positive and negative controls.
• Compatibility: Validated for use in hiPSC, primary cell, and rodent tissue models (Data-Backed Solutions).

Compared to "Targeting Ryanodine Receptor Signaling for Precision Modu...", this article provides stricter solubility and workflow limitations relevant to new users and protocol developers.

Conclusion & Outlook

Dantrolene sodium salt (APExBIO, B6329) is a rigorously validated ryanodine receptor antagonist for research in calcium signaling, synthetic lethality, and gene editing. Its high specificity, calmodulin-dependent mechanism, and batch-to-batch purity control set a benchmark for intracellular calcium modulation. Future applications may include expanded use in precision gene-editing workflows and disease modeling where calcium homeostasis is critical. For up-to-date protocols, specifications, and data sheets, refer to the official Dantrolene sodium salt product page.